Lynch Syndrome in Colorectal Cancer Surgery

Not yet recruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

July 1, 2026

Study Completion Date

August 1, 2026

Conditions
Colo-rectal CancerHereditary DiseasesLynch Syndrome
Interventions
DIAGNOSTIC_TEST

diagnostic test

"Group 1: MMR-Proficient Group Label: MMR-Proficient~Description: Patients with normal expression of MMR proteins on IHC analysis. No indication for further genetic testing.~Type: Observational Group~Group 2: dMMR Group Label: dMMR~Description: Patients with loss of MMR protein expression (MLH1, PMS2, MSH2, or MSH6) on IHC. These patients will undergo further molecular or genetic analysis to evaluate for Lynch syndrome.~Type: Observational Group"

All Listed Sponsors
lead

Izmir Ataturk Training and Research Hospital

OTHER